N‐acetylcysteine (1200 mg) vs placebo
Acute chest syndrome ( · sickle cell disease
It is very uncertain whether N‐acetylcysteine (1200 mg) changes frequency of sickle cell‐related complications (acute chest syndrome) compared with placebo (very low certainty).
1 finding from 1 review
- RR 5 [0.25, 101.48]1 study · 96 participantsVery low